# Mylan Pharmaceuticals Inc clinical trials: 160 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 160 trials with Mylan Pharmaceuticals Inc as lead sponsor, 1 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Mylan Pharmaceuticals Inc: 160 rows for $8, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/mylan-pharmaceuticals-inc

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 160
- Recruiting or not yet: 1
- Read on: November 19, 2026

## Trials

The 25 newest of 160, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| January 26, 2026 | NCT07365904 | Investigating Ovulation Inhibition for Use as a Contraceptive | Mylan Pharmaceuticals Inc | Phase 2 | Recruiting | Contraception | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07365904) |
| November 4, 2024 | NCT06672016 | Study to Evaluate Contraceptive Efficacy and Safety of a Progestin Only Patch in Women of Childbearing Potential | Mylan Pharmaceuticals Inc | Phase 3 | Active not recruiting | Female Contraception | 1,630 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06672016) |
| September 21, 2023 | NCT06048536 | Dose-finding Study of MR-130A-01 Contraceptive Transdermal Patch | Mylan Pharmaceuticals Inc | Phase 2 | Completed | Contraception | 168 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06048536) |
| December 19, 2020 | NCT04674800 | Extension Study of MYL-1701P-3001 for Safety and Efficacy | Mylan Pharmaceuticals Inc | Phase 3 | Completed | Diabetic Macular Edema | 52 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04674800) |
| November 18, 2020 | NCT04633564 | MYL-1402O Compared With Avastin®, in Patients With Stage IV nsNSCLC | Mylan Pharmaceuticals Inc | Phase 3 | Completed | NSCLC Stage IV | 671 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04633564) |
| August 1, 2018 | NCT03610646 | Comparative Study to Evaluate the Efficacy and Safety of MYL-1701P and Eylea® in Subjects With Diabetic Macular Edema (DME) | Mylan Pharmaceuticals Inc | Phase 3 | Completed | Diabetic Macular Edema | 355 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03610646) |
| November 3, 2015 | NCT02594761 | Phase 1 Study of Trastuzumab Administered as a Single Intravenous Infusion | Mylan Pharmaceuticals Inc | Phase 1 | Completed | Healthy | 132 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02594761) |
| July 21, 2014 | NCT02195986 | A Comparison of Estradiol Vaginal Cream to Estrace® Cream in 350 Postmenopausal Females With Atrophic Vaginitis | Mylan Pharmaceuticals Inc | Phase 3 | Completed | Atrophic Vaginitis | 366 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02195986) |
| April 9, 2014 | NCT02109185 | A Comparison of Mometasone Nasal Spray, Nasonex Nasal Spray, Nasonex Nasal Spray Suspension, & Placebo for Treatment of Seasonal Allergies... | Mylan Pharmaceuticals Inc | Phase 1 | Completed | Treatment of the Signs and Symptoms of Seasonal Allergic Rhinitis | 1,307 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02109185) |
| August 18, 2010 | NCT01184391 | Bioequivalence Study of Divalproex Sodium Delayed-Release Tablets, 500 mg | Mylan Pharmaceuticals Inc | Phase 1 | Completed | Healthy | 17 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01184391) |
| August 18, 2010 | NCT01183676 | Fed Bioequivalence Study of Divalproex Sodium Delayed-Release Tablets, 500 mg | Mylan Pharmaceuticals Inc | Phase 1 | Completed | Healthy | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01183676) |
| November 25, 2009 | NCT01020214 | Fasting Study of Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/25 mg and Benicar HCT® Tablets 40 mg/25 mg | Mylan Pharmaceuticals Inc | Phase 1 | Completed | Healthy | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01020214) |
| November 25, 2009 | NCT01019590 | Fed Study of Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/25 mg and Benicar HCT® Tablets 40 mg/25 mg | Mylan Pharmaceuticals Inc | Phase 1 | Completed | Healthy | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01019590) |
| November 23, 2009 | NCT01018342 | Fed Study of Mylan Nitrofurantoin Monohydrate/Macrocrystals Capsules 100 mg and Macrobid® Capsules 100 mg | Mylan Pharmaceuticals Inc | Phase 1 | Completed | Healthy | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01018342) |
| November 13, 2009 | NCT01012934 | Fasting Study of Alendronate Sodium Tablets (70 mg) and Fosamax Tablets (70 mg) | Mylan Pharmaceuticals Inc | Phase 1 | Completed | Healthy | 110 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01012934) |
| September 28, 2009 | NCT00985660 | Bioequivalence Study of Nisoldipine Extended-Release Tablets, 30 mg | Mylan Pharmaceuticals Inc | Phase 1 | Completed | Healthy | 78 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00985660) |
| September 24, 2009 | NCT00983996 | Fasting Study of Alendronate Sodium Tablets (10 mg) and Fosamax Tablets (10 mg) | Mylan Pharmaceuticals Inc | Phase 1 | Completed | Healthy | 112 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00983996) |
| September 18, 2009 | NCT00979537 | Single-Dose Fed Bioequivalence Study of Nisoldipine Extended-Release Tablets (40 mg; Mylan) and Sular® Extended-Release Tablets (40 mg... | Mylan Pharmaceuticals Inc | Phase 1 | Completed | Healthy | 83 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00979537) |
| September 16, 2009 | NCT00978055 | Fasting Study of Liothyronine Sodium Tablets (50 Mcg) to Cytomel® Tablets (50 Mcg) | Mylan Pharmaceuticals Inc | Phase 1 | Completed | Healthy | 31 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00978055) |
| August 8, 2008 | NCT00730197 | Fasting Bioequivalence Study of Nisoldipine Extended-Release Tablets 40 mg | Mylan Pharmaceuticals Inc | Phase 1 | Completed | Healthy | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00730197) |
| April 1, 2008 | NCT00650533 | Food Study of Glimepiride Tablets 1 mg to Amaryl® Tablets 1 mg | Mylan Pharmaceuticals Inc | Phase 1 | Completed | Healthy | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00650533) |
| April 1, 2008 | NCT00650520 | Fed Study of (Parlodel®) 2.5 mg Bromocriptine Mesylate Tablets | Mylan Pharmaceuticals Inc | Phase 1 | Completed | Healthy | 119 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00650520) |
| April 1, 2008 | NCT00650494 | Fed Study of Valacyclovir Hydrochloride Tablets 1000 mg and Valtrex® Tablets 1000 mg | Mylan Pharmaceuticals Inc | Phase 1 | Completed | Healthy | 66 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00650494) |
| April 1, 2008 | NCT00650481 | Fasting Study of Oxybutynin Chloride Extended-release Tablets 5 mg and Ditropan XL® Tablets 5 mg | Mylan Pharmaceuticals Inc | Phase 1 | Completed | Healthy | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00650481) |
| April 1, 2008 | NCT00650442 | Evaluation of Adhesion Quality and Irritation of an Alternate Second Generation Estradiol Transdermal System | Mylan Pharmaceuticals Inc | Phase 1 | Completed | Healthy | 39 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00650442) |

## By phase

| Phase | Trials |
| --- | --- |
| Early phase 1 | 2 |
| Phase 1 | 151 |
| Phase 2 | 2 |
| Phase 3 | 5 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 156 |
| Terminated | 2 |
| Recruiting | 1 |
| Active not recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Atrophic Vaginitis | 1 |
| Pruritus | 1 |
| Dysuria | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Rhinitis, Allergic, Seasonal | 1 |
| Nasal Obstruction | 1 |
| Sneezing | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Pharmaceutical companies in the United States](https://specstream.ai/data/businesses/pharmaceutical-companies/united-states)
- [Lumber stores in the United States](https://specstream.ai/data/businesses/lumber-stores/united-states)
- [Primary care clinics in the United States](https://specstream.ai/data/businesses/primary-care-clinics/united-states)
- [Textile mills in the United States](https://specstream.ai/data/businesses/textile-mills/united-states)
- [Ayurveda clinics in the United States](https://specstream.ai/data/businesses/ayurveda-clinics/united-states)
- [Comfort food restaurants in the United States](https://specstream.ai/data/businesses/comfort-food-restaurants/united-states)
